Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer
2011 ◽
Vol 13
(3)
◽
pp. 179-184
◽
Keyword(s):
Phase Ii
◽
2001 ◽
Vol 37
◽
pp. S272
◽